Real World Evidence: What It Is and How It Drives Innovation in Clinical Research - Cover

Real World Evidence: What It Is and How It Drives Innovation in Clinical Research

Clinical research is undergoing a major transformation. One of the key drivers of this change is the integration of Real World Data (RWD)—information collected outside traditional randomized controlled trials. These data are used to generate Real World Evidence (RWE), offering new insights into how treatments perform in the real world.

As regulatory bodies, pharmaceutical companies, and healthcare providers increasingly embrace RWE, the need for advanced digital platforms becomes clear. Tools like ACTide offer secure, interoperable solutions for managing this complex data landscape.

What Is Real World Evidence (RWE)?

Real World Evidence refers to the clinical evidence generated from the analysis of real-life data sources, such as:

  • Electronic health records (EHRs)
  • Patient registries
  • Wearable devices and mobile apps
  • Insurance claims and administrative data

Unlike traditional randomized controlled trials (RCTs), RWE reflects the effectiveness and safety of treatments across diverse patient populations and real-life settings.

This concept underpins Real Life Studies, which supplement RCTs by offering a more holistic view of patient outcomes.

Why Real World Evidence Matters in Clinical Research

RWE is becoming a strategic asset for regulators and pharmaceutical companies because it:

  • Complements RCTs by evaluating treatment safety and effectiveness in broader populations
  • Supports faster regulatory approvals (see FDA guidance)
  • Informs public health decisions and healthcare strategies

Real World Evidence is also central to value-based healthcare models, helping measure long-term impact and cost-effectiveness of therapies.

Challenges in Managing RWE

Despite its potential, working with RWE poses several challenges:

  • Data heterogeneity across sources and formats
  • Standardization, traceability, and auditability of datasets
  • Compliance with data protection regulations such as GDPR and the GCP guidelines (GCP E6(R3): AICRO’s Role in the New Clinical Research Landscape).
  • Need for interoperable, validated platforms to ensure scientific and regulatory reliability

These complexities demand flexible digital solutions tailored to observational and pragmatic study designs.

How ACTide Supports RWE Collection and Management

ACTide is a digital platform specifically designed to streamline data management in clinical research. It offers full support for RWE initiatives by enabling:

  • Structured and unstructured data capture from EHRs, wearables, PROs/ePROs
  • Custom data flows aligned with protocol-specific objectives
  • Full traceability and audit readiness
  • Outputs formatted for regulatory standards such as CDISC SDTM/ADaM
  • Seamless integration with AI-powered analytics tools

ACTide empowers sponsors, CROs, academic centers, and public health institutions to handle RWE with the same rigor as traditional clinical trials.

Want to discover how ACTide can help you leverage Real World Evidence in your clinical research strategy?

Real World Evidence: bridging research and real life

Real World Evidence is revolutionizing clinical research by providing insights that reflect real-life patient experiences. To fully leverage its value, organizations must adopt compliant, interoperable technologies that ensure data quality, transparency, and regulatory acceptance.

Learn how ACTide can help your organization collect and manage Real World Evidence with confidence:

Share

C

Information Request

Want more information about our solutions?
Contact us today.



















    Book a Demo Gratis

    See Actide in action — book a free, no-commitment demo and discover how it fits your business in minutes.